SCHEMBL23920437

SCHEMBL23920437

CCC(C)(C)c1nc(-c2ccc(-c3ccccc3)cc2)c2c(n1)oc1ccccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ HPGD P15428 2/20 0.35
▸ LMNA P02545 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ CSF1R P07333 1/20 0.34
▸ PDGFRB P09619 1/20 0.34
▸ KIT P10721 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ PSMD14 O00487 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ EGFR P00533 2/20 0.33
▸ IGF1R P08069 2/20 0.33
▸ FLT4 P35916 2/20 0.33
▸ KDR P35968 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24245609 0.92 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2HPGDLMNAKMT2A
SCHEMBL19162692 0.89 MEN1 (0.40) ALDH1A1SMN1; SMN2HPGDLMNAMAPT
SCHEMBL19161626 0.86 MEN1 (0.42) ALDH1A1SMN1; SMN2HPGDLMNAMAPT
SCHEMBL23874810 0.81 MAPT (0.45) ALDH1A1HPGDLMNAMAPTKMT2A
SCHEMBL23473799 0.80 PLA2G2A (0.37) ALDH1A1SMN1; SMN2HPGDLMNAMAPT
SCHEMBL27319462 0.80 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2HPGDLMNAMAPT
SCHEMBL19170016 0.78 SMN1; SMN2 (0.42) ALDH1A1SMN1; SMN2HPGDLMNAMAPT
SCHEMBL18017797 0.76 KMT2A (0.44) ALDH1A1SMN1; SMN2HPGDLMNAMAPT
SCHEMBL18017935 0.76 KMT2A (0.44) ALDH1A1SMN1; SMN2HPGDLMNAMAPT
SCHEMBL18370598 0.76 KMT2A (0.44) ALDH1A1SMN1; SMN2HPGDLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220045281-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2022-02-10 — — US disclosed
US-20210320263-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2021-10-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220045281-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ELAVL1, ICOSLG, OR10J3 ALDH1A1 784/4885SMN1; SMN2 729/4885HPGD 3378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback